Liver Cirrhosis

"Liver Cirrhosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Descriptor ID	D008103
MeSH Number(s)	C06.552.630
Concept/Terms	Liver Cirrhosis Liver Cirrhosis Cirrhosis, Liver Cirrhoses, Liver Liver Cirrhoses Hepatic Cirrhosis Cirrhoses, Hepatic Cirrhosis, Hepatic Hepatic Cirrhoses Fibrosis, Liver Fibrosis, Liver Fibroses, Liver Liver Fibroses Liver Fibrosis

Below are MeSH descriptors whose meaning is more general than "Liver Cirrhosis".

Diseases [C]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Liver Cirrhosis [C06.552.630]

Below are MeSH descriptors whose meaning is more specific than "Liver Cirrhosis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Liver Cirrhosis" by people in this website by year, and whether "Liver Cirrhosis" was a major or minor topic of these publications.

Bar chart showing 169 publications over 30 distinct years, with a maximum of 12 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	3	0	3
1998	5	2	7
1999	2	0	2
2000	2	1	3
2001	2	0	2
2002	6	0	6
2003	4	2	6
2004	3	0	3
2005	1	2	3
2006	3	3	6
2007	1	3	4
2008	3	1	4
2009	5	2	7
2010	6	1	7
2011	3	3	6
2012	5	0	5
2013	4	2	6
2014	5	3	8
2015	7	5	12
2016	4	3	7
2017	7	2	9
2018	3	2	5
2019	7	2	9
2020	4	6	10
2021	2	5	7
2022	0	7	7
2023	1	9	10
2024	1	1	2
2025	2	0	2

Below are the most recent publications written about "Liver Cirrhosis" by people in Profiles.

Yeramaneni S, Chang ST, Cheung RC, Chalfin DB, Sangha K, Levy HR, Boltyenkov AT. Comparison of Referral Rates and Costs Using Fibrosis-4 and Enhanced Liver Fibrosis (ELF) Testing Strategies for Initial Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Veteran Population. J Appl Lab Med. 2025 May 02; 10(3):593-604.

View in: PubMed
Degasperi E, Anolli MP, Jachs M, Reiberger T, De Ledinghen V, Metivier S, D'Offizi G, di Maria F, Schramm C, Schmidt H, Z?llner C, Tacke F, Dietz-Fricke C, Wedemeyer H, Papatheodoridi M, Papatheodoridis G, Carey I, Agarwal K, Van B?mmel F, Brunetto MR, Cardoso M, Verucchi G, Ciancio A, Zoulim F, Aleman S, Semmo N, Mangia A, Hilleret MN, Merle U, Santantonio TA, Coppola N, Pellicelli A, Roche B, Causse X, D'Alteroche L, Dumortier J, Ganne N, Heluwaert F, Ollivier I, Roulot D, Vigan? M, Loglio A, Federico A, Pileri F, Maracci M, Tonnini M, Arpurt JP, Barange K, Billaud E, Pol S, Gervais A, Minello A, Rosa I, Puoti M, Lampertico P. Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis. J Hepatol. 2025 06; 82(6):1012-1022.

View in: PubMed
Zeng G, Krishnamurthy S, Staats Pires A, Guller A, Chaganti J, Tun N, Lockart I, Montagnese S, Brew B, Guillemin GJ, Danta M, Heng B. Activation of the kynurenine pathway identified in individuals with covert hepatic encephalopathy. Hepatol Commun. 2024 12 01; 8(12).

View in: PubMed
Verma M, Chan M, Toroghi S, Gallagher M, Lo K, Navarro V. Multimedia-Based Education Led to Improvement in Disease Knowledge Among Patients with Cirrhosis. Dig Dis Sci. 2024 Dec; 69(12):4364-4372.

View in: PubMed
Ahmed Z, Badal J, Gangwani MK, Nawaz A, Badal B, Arif SF, Farooq U, Kamal F, Javaid T, Aziz M, Lee-Smith W, Mahmood A, Merza N, Kobeissy A, Nawras A, Hassan M. Sarcopenia is a risk factor for post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy and mortality: A systematic review and meta-analysis. Indian J Gastroenterol. 2024 08; 43(4):748-759.

View in: PubMed
Robbins J, Halegoua-DeMarzio D, Basu Mallick A, Vijayvergia N, Ganetzky R, Lavu H, Giri VN, Miller J, Maley W, Shah AP, DiMeglio M, Ambelil M, Yu R, Sato T, Lefler DS. Liver Transplantation in a Woman with Mahvash Disease. N Engl J Med. 2023 11 23; 389(21):1972-1978.

View in: PubMed
Khair AM, McIlvain G, McGarry MDJ, Kandula V, Yue X, Kaur G, Averill LW, Choudhary AK, Johnson CL, Nikam RM. Clinical application of magnetic resonance elastography in pediatric neurological disorders. Pediatr Radiol. 2023 12; 53(13):2712-2722.

View in: PubMed
Parra NS, Schafer M, Ross HM, Bruckbauer J, Yan B, Chen SL, Khan A, Tholey DM, Halegoua-DeMarzio D. Prevalence of post-liver transplant complications and NASH-related cirrhosis in postmenopausal women. Ann Hepatol. 2024 Jan-Feb; 29(1):101157.

View in: PubMed
Torkzaban M, Wessner CE, Halegoua-DeMarzio D, Lyshchik A, Nam K. Diagnostic Performance of Quantitative Ultrasound Parameters in Non-alcoholic Fatty Liver Disease. Acad Radiol. 2024 01; 31(1):199-211.

View in: PubMed
Tahmasebi A, Wessner CE, Guglielmo FF, Wang S, Vu T, Liu JB, Civan J, Lyshchik A, Forsberg F, Li H, Qu E, Eisenbrey JR. Comparison of Magnetic Resonance-Based Elastography and Ultrasound Shear Wave Elastography in Patients With Suspicion of Nonalcoholic Fatty Liver Disease. Ultrasound Q. 2023 Jun 01; 39(2):100-108.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement